Hematology
From the Journals
Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A
Inhibitors occurred at an early age of 13 years with a prevalence of 2.6%, but were not associated with increased mortality.
From the Journals
DOACs look safe in elective endoscopic procedures
The study also found delaying resumption of anticoagulants provided no benefit.
Guidance for Practicing Primary Care
ASH guidelines for venous thromboembolism: What family physicians need to know
A recommendation regarding the use of DOACs may ease some of the burden of monitoring patients on long-term Coumadin.
From the Journals
Caregiver burden of outpatient ASCT for multiple myeloma comparable with inpatient transplant
But only if caregivers are equipped for outpatient care.
Conference Coverage
Cost is the main hurdle to broad use of caplacizumab for TTP
“If we take finances out, I think almost every patient except those with a bleeding risk or bleeding problem should get it,” an investigator said...
Conference Coverage
VTE prophylaxis is feasible, effective in some high-risk cancer patients
Conference Coverage
What to do when anticoagulation fails cancer patients
Feature
CMS launches hospital-at-home program to free up hospital capacity
The agency will be giving more flexibility to ambulatory surgery centers (ASCs) to provide hospital-level care.
From the Journals
Hemophilia, von Willebrand disease do not increase postop complications for ACL reconstruction
A case-control study showed outcomes were similar but hospital costs were significantly higher for patients with bleeding disorders.
Conference Coverage
Factor XI inhibitor–based anticoagulation strategies gain ground
“When we compare the FXI inhibitors with existing anticoagulants, we don’t necessarily want to go up against the DOACs.”
From the Journals
Mouth splints decrease risk of post–dental extraction bleeding in hemophilia